Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Nuravax develops and researches on vaccines, preventive solutions and treatment for neurodegenerative disorders.
Epicore Biosystems is a digital health solutions company that develops sweat-sensing wearables, providing personalized health insights.
Amissa powers evidence-based perimenopause care with AI-enabled clinical decision support.
GelSana Therapeutics develops novel advanced polymers to improve wound healing
Ria Health is an online platform providing telehealth services for alcohol use disorder.
Stem Pharm's synthetic biomaterials support the optimization of cell expansion.
Peel Therapeutics is a biotech company that develops medicines for cancer and inflammatory diseases.
Arcascope makes apps that utilize algorithms that track circadian rhythms and generates personalized recommendations.
Mustang Bio is a clinical-stage biopharmaceutical company .
Amplo Biotechnology is to develop multiple, potentially curative, Adeno-Associated Viral (AAV) therapies for the neuromuscular junction.
IotaMotion is a medical technology company developing robotics-assisted solutions for cochlear implant surgery.
IVOS Medical is a startup medical device specializing company in airway management.
Rhealth is a biotechnology company that provides health management solutions based on advanced AI through a platform to hospitals.
Thetis Pharmaceuticals is a biopharmaceutical company.
Trace Biosciences creates fluorescence imaging agents for real-time nerve visualization during surgery.
PhotoniCare is a medical device company that develops diagnostic tools to improve clinical outcomes and address unmet patient needs.
HQ Science is a biotechnology company at the forefront of molecular diagnostics innovation.
Sparian Biosciences is a biopharmaceutical company.
NextStep Robotics is developing the first effective treatment option for foot drop to help stroke survivors.
Brixton Biosciences is a clinical-stage life sciences company that develops therapies for chronic and acute pain.
YoungHeartValve is a Polymeric Hyaluronan-Enhanced Transcatheter Aortic Valves which were developed by engineers by inspiration from nature.
Pip Care provides a personalized surgical journey platform, optimizing perioperative care processes and supporting patients and care teams.
Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies to reverse neurodegeneration.
Self-Driven Neurological Assessments
National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Biotechnology, Health Care, Medical, Medical Device, Pharmaceutical. The firm invests across 30 different industry categories.
Among tracked funding rounds, Sparian Biosciences received $19.5M in a Grant round. National Institutes of Health's total known invested capital is $2.5B.
National Institutes of Health's average investment size is $5.9M across its portfolio of 491 companies.
Recent National Institutes of Health portfolio additions include Nuravax, Epicore Biosystems, Amissa Health, GelSana, Ria Health. These companies were founded in 2020 or later.